ClinicalTrialsFinder

Renal Cell Cancer, Recurrent Clinical Trials in Sydney, New South Wales

1 recruitingSydney, New South Wales, Australia

Showing 1–1 of 1 trials

Recruiting
Phase 3

Phase 3 Study to Assess Safety and Efficacy of 177Lu-TLX250 in Advanced Relapsed or Recurrent ccRCC

Renal Cell Carcinoma (RCC)Clear Cell Renal Cell Cancer (ccRCC)Renal Cell Carcinoma (Kidney Cancer)+3 more
Telix Pharmaceuticals (Innovations) Pty Limited40 enrolled5 locationsNCT07197580